search
Back to results

Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth (APEXMTA)

Primary Purpose

Dental Pulp Necrosis

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Mineral Trioxide Aggregate
Calcium hydroxide
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Pulp Necrosis focused on measuring Apexification, Pulp necrosis, Calcium hydroxide, MTA, pulp necrosis of an anterior immature tooth

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Indication of apexification treatment of an anterior immature tooth
  • Patients aged 6 to 18
  • Enlightened agreement of the patient and his/her legal representatives
  • Prerequisite medical examination

Exclusion Criteria:

General disease

  • diabetes
  • immunosuppression of whatever origin (AIDS, drugs, …)
  • severe asthma
  • chronical disease requiring treatment
  • eating disorders (anorexia, bulimia, malnutrition, …) Oral disease
  • periodontal disease
  • Administration of corticoids in a period of 3 months preceding the inclusion
  • Patient with no social security cover

Sites / Locations

  • Hôpital Bretonneau

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Calcium hydroxide

MTA

Arm Description

Outcomes

Primary Outcome Measures

Main success criterion: presence of a calcified apical barrier or not at 3, 6 and 12 months

Secondary Outcome Measures

Additional criterions :- presence of clinical symptoms or not- apical morphology - depth of this apical barrier At 3, 6 and 12 months

Full Information

First Posted
May 10, 2007
Last Updated
November 9, 2011
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00472173
Brief Title
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth
Acronym
APEXMTA
Official Title
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
May 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Pulp necrosis is one of the main complication of dental trauma. When it happens on an immature tooth, pulp necrosis implies a lack of root maturation and apical closure. A therapy called apexification is required to induce the formation of a calcified apical barrier allowing a permanent and hermetic root filling.The aim of this study is to compare the efficacy of a new apexification method using Mineral Trioxide Aggregate (MTA®) with the reference treatment based on calcium hydroxide repeated stimulations.
Detailed Description
36 patients aged 6 to 18 and presenting a non vital immature tooth will be included in the study (inclusion period: 12 months). These patients will be randomly divided into two groups: one treated with MTA®, and the other one with calcium hydroxide. For each patient, the total duration of the study will be 12 months. Recalls will be performed at 15 and 21 days and then at 3, 6 and 12 months to assess by clinical and X-ray exams the main success criterion: presence of a calcified apical barrier or not. Additional criterions such as presence of clinical symptoms or not, apical morphology and depth of this apical barrier will be observed. This randomised prospective therapeutic study will allow to assess the ability of MTA® inducing apexification of a non vital immature tooth. Furthermore, it will be possible to compare for both materials the kinetics of clinical symptoms disappearance and the morphology and depth of apices.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Pulp Necrosis
Keywords
Apexification, Pulp necrosis, Calcium hydroxide, MTA, pulp necrosis of an anterior immature tooth

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Calcium hydroxide
Arm Type
Active Comparator
Arm Title
MTA
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Mineral Trioxide Aggregate
Intervention Description
Apexification treatment of the tooth with Mineral Trioxide Aggregate
Intervention Type
Drug
Intervention Name(s)
Calcium hydroxide
Intervention Description
Apexification treatment of the tooth with Calcium hydroxide
Primary Outcome Measure Information:
Title
Main success criterion: presence of a calcified apical barrier or not at 3, 6 and 12 months
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Additional criterions :- presence of clinical symptoms or not- apical morphology - depth of this apical barrier At 3, 6 and 12 months
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication of apexification treatment of an anterior immature tooth Patients aged 6 to 18 Enlightened agreement of the patient and his/her legal representatives Prerequisite medical examination Exclusion Criteria: General disease diabetes immunosuppression of whatever origin (AIDS, drugs, …) severe asthma chronical disease requiring treatment eating disorders (anorexia, bulimia, malnutrition, …) Oral disease periodontal disease Administration of corticoids in a period of 3 months preceding the inclusion Patient with no social security cover
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Jacques Lasfargues, Dentist PhD
Organizational Affiliation
Hôpital Bretonneau - Paris
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Raphaël SERREAU, MD, PhD
Organizational Affiliation
URC Paris Centre
Official's Role
Study Director
Facility Information:
Facility Name
Hôpital Bretonneau
City
Paris
ZIP/Postal Code
75018
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
21752247
Citation
Beslot-Neveu A, Bonte E, Baune B, Serreau R, Aissat F, Quinquis L, Grabar S, Lasfargues JJ. Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: study protocol for a randomized controlled trial. Trials. 2011 Jul 13;12:174. doi: 10.1186/1745-6215-12-174.
Results Reference
derived

Learn more about this trial

Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth

We'll reach out to this number within 24 hrs